特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
669945

喘息・COPD治療薬の世界市場:産業分析・成長予測・競合分析:2018年~2025年

Global Asthma and COPD Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

出版日: | 発行: QYResearch | ページ情報: 英文 97 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
喘息・COPD治療薬の世界市場:産業分析・成長予測・競合分析:2018年~2025年
出版日: 2018年08月02日
発行: QYResearch
ページ情報: 英文 97 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の喘息・COPD治療薬市場は予測期間中5.6%のCAGR (年間複合成長率) で推移し、2017年の52億米ドルから、2025年までには80億4,000万米ドルの規模に成長すると予測されています。

当レポートでは、世界の喘息・COPD治療薬市場を調査し、市場および製品の概要、生産・消費規模の推移と予測、用途・タイプ・地域/主要国別の内訳、市場成長への各種影響因子の分析、競合環境と市場シェア、主要メーカーのプロファイルなどをまとめています。

第1章 レポート概要

  • 調査範囲
  • 主要メーカー
  • 市場区分:種類別
  • 市場区分:用途別
  • 調査対象
  • 調査対象年

第2章 世界の成長動向

  • 生産量・生産能力の分析
  • 主要メーカーのCAGR (年間複合成長率)
  • 産業動向

第3章 メーカーの市場シェア

  • 生産能力・生産量:メーカー別
  • 収益:メーカー別
  • 薬価:メーカー別
  • 主要メーカーの工場の分布・販売エリア
  • 主要メーカーの市場参入時期
  • 主要メーカーの提供製品
  • M&A・拡張計画

第4章 市場規模:タイプ別

  • 各タイプの生産規模 (数量ベース・金額ベース)
  • 生産規模のシェア (数量ベース)
  • 生産規模のシェア (金額ベース)
  • 工場渡し価格

第5章 市場規模:用途別

  • 概要
  • 消費:用途別

第6章 生産:地域別

  • 生産規模 (数量ベース) :地域別
  • 生産規模 (金額ベース) :地域別
  • 米国
  • 欧州
  • 中国
  • 日本
  • その他の地域
    • 韓国
    • インド
    • 東南アジア

第7章 消費の推移:地域別

  • 世界の消費:地域別
  • 北米
    • タイプ別
    • 用途別
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • タイプ別
    • 用途別
    • 国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
  • アジア太平洋
    • タイプ別
    • 用途別
    • 国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン
    • ベトナム
  • 中南米
    • タイプ別
    • 用途別
    • 国別
    • ブラジル
  • 中東・アフリカ
    • タイプ別
    • 用途別

第8章 企業プロファイル

  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Merck and Co
  • Novartis AG
  • AstraZeneca
  • F. Hoffmann-La Roche

第9章 市場予測:生産サイド

  • 生産 (数量ベース・金額ベース) の予測
  • 生産 (数量ベース・金額ベース) の予測:地域別
  • 主要メーカーの予測
  • 予測:タイプ別

第10章 市場予測:消費サイド

  • 消費の予測:用途別
  • 消費の予測:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第11章 バリューチェーン・販売経路の分析

第12章 市場機会・課題・脅威・影響因子

第13章 主要調査結果

第14章 付録

図表

List of Tables and Figures

  • Figure Asthma and COPD Drug Product Picture
  • Table Asthma and COPD Drug Key Market Segments
  • Table Major Manufacturers Asthma and COPD Drug Covered in This Report
  • Table Global Asthma and COPD Drug Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Asthma and COPD Drug Sales Market Shar by Type 2013-2025
  • Figure Bronchodilators Figures
  • Table Major Manufacturers of Bronchodilators
  • Figure Anti-inflammatory Drugs Figures
  • Table Major Manufacturers of Anti-inflammatory Drugs
  • Figure Monoclonal Antibodies Figures
  • Table Major Manufacturers of Monoclonal Antibodies
  • Figure Combination Drugs Figures
  • Table Major Manufacturers of Combination Drugs
  • Table Global Asthma and COPD Drug Market Share by Application 2018-2025 (K Units)
  • Figure Asthma Use Case
  • Figure COPD Use Case
  • Figure Asthma and COPD Drug Report Years Considered
  • Figure Global Asthma and COPD Drug Production Value Growth Rate 2013-2025 (Million US$)
  • Figure Global Asthma and COPD Drug Production 2013-2025 (K Units)
  • Figure Global Asthma and COPD Drug Capacity 2013-2025 (K Units)
  • Table Key Manufacturers Asthma and COPD Drug Capacity (K Units)
  • Figure Global Asthma and COPD Drug Price 2013-2025 (USD/Unit)
  • Table Global Asthma and COPD Drug Market Size of Key Regions (Million USD) & (K Units)
  • Table Global Asthma and COPD Drug Growth Rate of Key Regions 2018-2025 (Million USD)
  • Table Global Asthma and COPD Drug Market Share for of Regions 2018-2025 (K Units)
  • Table Market Top Trends
  • Table Global Asthma and COPD Drug Capacity by Manufacturers (2013-2018) (K Units)
  • Table Global Asthma and COPD Drug Capacity Market Share by Manufacturers (2013-2018)
  • Table Global Asthma and COPD Drug Production by Manufacturers (2013-2018) (K Units)
  • Table Global Asthma and COPD Drug Production Share by Manufacturers (2013-2018)
  • Figure Global Asthma and COPD Drug Production Share by Manufacturers in 2017
  • Table Asthma and COPD Drug Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Asthma and COPD Drug Revenue Share by Manufacturers (2013-2018)
  • Figure Asthma and COPD Drug Value Share by Manufacturers in 2017
  • Table Global Asthma and COPD Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Asthma and COPD Drug Price by Manufacturers 2013-2018 (USD/Unit)
  • Table Key Manufacturers Asthma and COPD Drug Plants/Factories Distribution
  • Table Key Manufacturers Asthma and COPD Drug Area Served
  • Table Date of Key Manufacturers Enter into Asthma and COPD Drug Market
  • Table Key Manufacturers Asthma and COPD Drug Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Bronchodilators Production and Production Value (2013-2018) (K Units) & (Million US$)
  • Table Global Anti-inflammatory Drugs Production and Production Value (2013-2018) (K Units) & (Million US$)
  • Table Global Monoclonal Antibodies Production and Production Value (2013-2018) (K Units) & (Million US$)
  • Table Global Combination Drugs Production and Production Value (2013-2018) (K Units) & (Million US$)
  • Table Global Asthma and COPD Drug Production by Type (2013-2018) (K Units)
  • Table Global Asthma and COPD Drug Production Share by Type (2013-2018)
  • Figure Global Asthma and COPD Drug Production Market Share by Type (2013-2018)
  • Figure Global Asthma and COPD Drug Production Market Share by Type in 2017
  • Table Global Asthma and COPD Drug Production Value by Type (2013-2018) (Million US$)
  • Table Global Asthma and COPD Drug Production Value Share by Type (2013-2018)
  • Figure Global Asthma and COPD Drug Production Value Market Share by Type (2013-2018)
  • Figure Global Asthma and COPD Drug Production Value Market Share by Type in 2017
  • Table Asthma and COPD Drug Ex-factory Price by Type 2013-2018 (USD/Unit)
  • Table Global Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Table Global Asthma and COPD Drug Consumption Share by Application (2013-2018)
  • Figure Global Consumption Asthma and COPD Drug Market Share by Application (2013-2018)
  • Table Global Asthma and COPD Drug Production by Regions 2013-2018 (K Units)
  • Table Global Asthma and COPD Drug Production Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Production Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Production Market Share by Regions in 2017
  • Table Global Asthma and COPD Drug Production Value by Regions 2013-2018 (Million USD)
  • Table Global Asthma and COPD Drug Production Value Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Production Value Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Production Value Market Share by Regions in 2017
  • Table United States Asthma and COPD Drug Production and Value 2013-2018 (K Units) & (Million USD)
  • Figure United States Asthma and COPD Drug Production Growth Rate 2013-2018 (K Units)
  • Figure United States Asthma and COPD Drug Production Value Growth Rate 2013-2018 (Million USD)
  • Table United States Asthma and COPD Drug Import & Export (K Units)
  • Table Europe Asthma and COPD Drug Production and Value 2013-2018 (K Units) & (Million USD)
  • Figure Europe Asthma and COPD Drug Production Growth Rate 2013-2018 (K Units)
  • Figure Europe Asthma and COPD Drug Production Value Growth Rate 2013-2018 (Million USD)
  • Table Europe Asthma and COPD Drug Import & Export (K Units)
  • Table China Asthma and COPD Drug Production and Value 2013-2018 (K Units) & (Million USD)
  • Figure China Asthma and COPD Drug Production Growth Rate 2013-2018 (K Units)
  • Figure China Asthma and COPD Drug Production Value Growth Rate 2013-2018 (Million USD)
  • Table China Asthma and COPD Drug Import & Export (K Units)
  • Table Japan Asthma and COPD Drug Production and Value 2013-2018 (K Units) & (Million USD)
  • Figure Japan Asthma and COPD Drug Production Growth Rate 2013-2018 (K Units)
  • Figure Japan Asthma and COPD Drug Production Value Growth Rate 2013-2018 (Million USD)
  • Table Japan Asthma and COPD Drug Import & Export (K Units)
  • Table Global Asthma and COPD Drug Consumption by Regions 2013-2018 (K Units)
  • Table Global Asthma and COPD Drug Consumption Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Consumption Market Share by Regions 2013-2018
  • Figure Global Asthma and COPD Drug Consumption Market Share by Regions in 2017
  • Figure North America Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Table North America Asthma and COPD Drug Consumption by Type (2013-2018) (K Units)
  • Figure North America Asthma and COPD Drug Consumption Market Share by Type in 2018
  • Table North America Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Figure North America Asthma and COPD Drug Consumption Market Share by Application in 2018
  • Table North America Asthma and COPD Drug Consumption by Countries (2013-2018) (K Units)
  • Figure North America Asthma and COPD Drug Consumption Market Share by Countries in 2018
  • Figure United States Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Canada Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Mexico Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Europe Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Table Europe Asthma and COPD Drug Consumption by Type (2013-2018) (K Units)
  • Figure Europe Asthma and COPD Drug Consumption Market Share by Type in 2018
  • Table Europe Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Figure Europe Asthma and COPD Drug Consumption Market Share by Application in 2018
  • Table Europe Asthma and COPD Drug Consumption by Countries (2013-2018) (K Units)
  • Figure Europe Asthma and COPD Drug Consumption Market Share by Countries in 2018
  • Figure Germany Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure France Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure UK Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Italy Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Russia Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Table Asia Pacific Asthma and COPD Drug Consumption by Type (2013-2018) (K Units)
  • Figure Asia Pacific Asthma and COPD Drug Consumption Market Share by Type in 2018
  • Table Asia Pacific Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Figure Asia Pacific Asthma and COPD Drug Consumption Market Share by Application in 2018
  • Table Asia Pacific Asthma and COPD Drug Consumption by Countries (2013-2018) (K Units)
  • Table Asia Pacific Asthma and COPD Drug Consumption Market Share by Countries (2013-2018)
  • Figure China Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Japan Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Korea Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure India Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Australia Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Thailand Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Philippines Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Central & South America Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Table Central & South America Asthma and COPD Drug Consumption by Type (2013-2018) (K Units)
  • Figure Central & South America Asthma and COPD Drug Consumption Market Share by Type in 2018
  • Table Central & South America Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Figure Central & South America Asthma and COPD Drug Consumption Market Share by Application in 2018
  • Table Central & South America Asthma and COPD Drug Consumption by Countries (2013-2018) (K Units)
  • Figure Central & South America Asthma and COPD Drug Consumption Market Share by Countries
  • Figure Brazil Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Asthma and COPD Drug Consumption Growth Rate (2013-2018) (K Units)
  • Table Middle East and Africa Asthma and COPD Drug Consumption by Type (2013-2018) (K Units)
  • Figure 2017 Middle East and Africa Asthma and COPD Drug Consumption Market Share by Type
  • Table Middle East and Africa Asthma and COPD Drug Consumption by Application (2013-2018) (K Units)
  • Figure 2017 Middle East and Africa Asthma and COPD Drug Consumption Market Share by Application
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Boehringer Ingelheim Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table Boehringer Ingelheim Asthma and COPD Drug Production Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table GlaxoSmithKline Company Details
  • Table GlaxoSmithKline Description and Business Overview
  • Table GlaxoSmithKline Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table GlaxoSmithKline Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table GlaxoSmithKline Asthma and COPD Drug Production Market Share in Global Market
  • Table GlaxoSmithKline Recent Development
  • Table Merck and Co Company Details
  • Table Merck and Co Description and Business Overview
  • Table Merck and Co Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Merck and Co Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table Merck and Co Asthma and COPD Drug Production Market Share in Global Market
  • Table Merck and Co Recent Development
  • Table Novartis AG Company Details
  • Table Novartis AG Description and Business Overview
  • Table Novartis AG Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Novartis AG Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table Novartis AG Asthma and COPD Drug Production Market Share in Global Market
  • Table Novartis AG Recent Development
  • Table AstraZeneca Company Details
  • Table AstraZeneca Description and Business Overview
  • Table AstraZeneca Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table AstraZeneca Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table AstraZeneca Asthma and COPD Drug Production Market Share in Global Market
  • Table AstraZeneca Recent Development
  • Table F. Hoffmann-La Roche Company Details
  • Table F. Hoffmann-La Roche Description and Business Overview
  • Table F. Hoffmann-La Roche Asthma and COPD Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table F. Hoffmann-La Roche Asthma and COPD Drug Production Growth Rate (2013-2018)
  • Table F. Hoffmann-La Roche Asthma and COPD Drug Production Market Share in Global Market
  • Table F. Hoffmann-La Roche Recent Development
  • Table Global Asthma and COPD Drug Capacity, Production Forecast 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Capacity Forecast 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Forecast 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Value Forecast 2018-2025 (Million US$)
  • Table Global Asthma and COPD Drug Revenue Forecast 2018-2025 (Million US$)
  • Table Global Asthma and COPD Drug Production Value Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Asthma and COPD Drug Production Value Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Asthma and COPD Drug Production Value Market Share Forecast by Regions 2018-2025
  • Table Global Asthma and COPD Drug Production Forecast by Regions 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Forecast by Regions 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Market Share Forecast by Regions 2018-2025
  • Table United States Asthma and COPD Drug Production and Value Forecast 2018-2025 (K Units) & (Million US$)
  • Figure United States Asthma and COPD Drug Production Forecast 2018-2025 (K Units)
  • Figure United States Asthma and COPD Drug Revenue Forecast 2018-2025 (Million US$)
  • Table Europe Asthma and COPD Drug Production and Value Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Europe Asthma and COPD Drug Production Forecast 2018-2025 (K Units)
  • Figure Europe Asthma and COPD Drug Revenue Forecast 2018-2025 (Million US$)
  • Table China Asthma and COPD Drug Production and Value Forecast 2018-2025 (K Units) & (Million US$)
  • Figure China Asthma and COPD Drug Production Forecast 2018-2025 (K Units)
  • Figure China Asthma and COPD Drug Revenue Forecast 2018-2025 (Million US$)
  • Table Japan Asthma and COPD Drug Production and Value Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Japan Asthma and COPD Drug Production Forecast 2018-2025 (K Units)
  • Figure Japan Asthma and COPD Drug Revenue Forecast 2018-2025 (Million US$)
  • Table Global Asthma and COPD Drug Production Forecast by Type 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Forecast by Type 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Production Market Share Forecast by Type 2018-2025
  • Table Global Asthma and COPD Drug Production Value Forecast by Type 2018-2025 (Million US$)
  • Figure Global Asthma and COPD Drug Production Value Forecast by Type 2018-2025 (Million US$)
  • Figure Global Asthma and COPD Drug Production Value Market Share Forecast by Type 2018-2025
  • Table Global Asthma and COPD Drug Consumption Forecast by Application 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Consumption Forecast by Application 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Consumption Market Share Forecast by Application 2018-2025
  • Table Global Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure Global Asthma and COPD Drug Consumption Market Share Forecast by Regions 2018-2025
  • Table North America Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure United States Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Canada Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure MexicoAsthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Table Europe Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure Germany Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure France Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure UK Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Italy Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Russia Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Table Asia Pacific Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure China Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Japan Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Korea Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure India Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Australia Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Indonesia Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Thailand Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Malaysia Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Philippines Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure Vietnam Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Table Central & South America Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure Brazil Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Asthma and COPD Drug Consumption Forecast by Regions 2018-2025 (K Units)
  • Figure Middle East and Africa Asthma and COPD Drug Consumption Forecast 2018-2025 (K Units)
  • Figure GCC Countries Asthma and COPD Drug Sales Growth Rate (2018-2025) (K Units)
  • Figure Egypt Asthma and COPD Drug Sales Growth Rate (2018-2025) (K Units)
  • Figure South Africa Asthma and COPD Drug Sales Growth Rate (2018-2025) (K Units)
  • Figure Asthma and COPD Drug Value Chain
  • Table Asthma and COPD Drug Distributors List
  • Table Asthma and COPD Drug Customers List
  • Table Porter's Five Forces Analysis
  • Figure GDP for Major Regions in 2016
  • Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
  • Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
  • Figure Saving Rate Total, % of GDP, 2015
  • Figure Price of raw materials in dollars: Evolution
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

This study focuses on the production side and consumption side of Asthma and COPD Drug, presents the global Asthma and COPD Drug market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

In terms of production side, this report researches the Asthma and COPD Drug capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.

In terms of consumption side, this report focuses on the consumption of Asthma and COPD Drug by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.

The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.

The Asthma and COPD Drug market was valued at 5200 Million US$ in 2017 and is projected to reach 8040 Million US$ by 2025, at a CAGR of 5.6% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Asthma and COPD Drug.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Merck and Co
  • Novartis AG
  • AstraZeneca
  • F. Hoffmann-La Roche

Market Segment by Product Type

  • Bronchodilators
  • Anti-inflammatory Drugs
  • Monoclonal Antibodies
  • Combination Drugs

Market Segment by Application

  • Asthma
  • COPD

Key Regions split in this report:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa

The study objectives are:

  • To analyze and research the global Asthma and COPD Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Asthma and COPD Drug manufacturers, capacity, production, revenue, market share, and recent development.
  • To split the breakdown data by regions, type, manufacturers and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma and COPD Drug are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Asthma and COPD Drug Market Size Growth Rate by Type
    • 1.3.2. Bronchodilators
    • 1.3.3. Anti-inflammatory Drugs
    • 1.3.4. Monoclonal Antibodies
    • 1.3.5. Combination Drugs
  • 1.4. Market Segment by Application
    • 1.4.1. Global Asthma and COPD Drug Market Share by Application (2018-2025)
    • 1.4.2. Asthma
    • 1.4.3. COPD
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Production and Capacity Analysis
    • 2.1.1. Global Asthma and COPD Drug Production Value 2013-2025
    • 2.1.2. Global Asthma and COPD Drug Production 2013-2025
    • 2.1.3. Global Asthma and COPD Drug Capacity 2013-2025
    • 2.1.4. Global Asthma and COPD Drug Marketing Pricing and Trends
  • 2.2. Key Producers Growth Rate (CAGR) 2018-2025
    • 2.2.1. Global Asthma and COPD Drug Market Size CAGR of Key Regions
    • 2.2.2. Global Asthma and COPD Drug Market Share of Key Regions
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Capacity and Production by Manufacturers
    • 3.1.1. Global Asthma and COPD Drug Capacity by Manufacturers
    • 3.1.2. Global Asthma and COPD Drug Production by Manufacturers
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Asthma and COPD Drug Revenue by Manufacturers (2013-2018)
    • 3.2.2. Asthma and COPD Drug Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Asthma and COPD Drug Market Concentration Ratio (CR5 and HHI)
  • 3.3. Asthma and COPD Drug Price by Manufacturers
  • 3.4. Key Manufacturers Asthma and COPD Drug Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Asthma and COPD Drug Market
  • 3.6. Key Manufacturers Asthma and COPD Drug Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Production and Production Value for Each Type
    • 4.1.1. Bronchodilators Production and Production Value (2013-2018)
    • 4.1.2. Anti-inflammatory Drugs Production and Production Value (2013-2018)
    • 4.1.3. Monoclonal Antibodies Production and Production Value (2013-2018)
    • 4.1.4. Combination Drugs Production and Production Value (2013-2018)
  • 4.2. Global Asthma and COPD Drug Production Market Share by Type
  • 4.3. Global Asthma and COPD Drug Production Value Market Share by Type
  • 4.4. Asthma and COPD Drug Ex-factory Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Asthma and COPD Drug Consumption by Application

6. Production by Regions

  • 6.1. Global Asthma and COPD Drug Production (History Data) by Regions 2013-2018
  • 6.2. Global Asthma and COPD Drug Production Value (History Data) by Regions
  • 6.3. United States
    • 6.3.1. United States Asthma and COPD Drug Production Growth Rate 2013-2018
    • 6.3.2. United States Asthma and COPD Drug Production Value Growth Rate 2013-2018
    • 6.3.3. Key Players in United States
    • 6.3.4. United States Asthma and COPD Drug Import & Export
  • 6.4. Europe
    • 6.4.1. Europe Asthma and COPD Drug Production Growth Rate 2013-2018
    • 6.4.2. Europe Asthma and COPD Drug Production Value Growth Rate 2013-2018
    • 6.4.3. Key Players in Europe
    • 6.4.4. Europe Asthma and COPD Drug Import & Export
  • 6.5. China
    • 6.5.3. Key Players in China
    • 6.5.2. China Asthma and COPD Drug Production Value Growth Rate 2013-2018
    • 6.5.3. Key Players in China
    • 6.5.4. China Asthma and COPD Drug Import & Export
  • 6.6. Japan
    • 6.6.1. Japan Asthma and COPD Drug Production Growth Rate 2013-2018
    • 6.6.2. Japan Asthma and COPD Drug Production Value Growth Rate 2013-2018
    • 6.6.3. Key Players in Japan
    • 6.6.4. Japan Asthma and COPD Drug Import & Export
  • 6.7. Other Regions
    • 6.7.1. South Korea
    • 6.7.2. India
    • 6.7.3. Southeast Asia

7. Asthma and COPD Drug Consumption by Regions

  • 7.1. Global Asthma and COPD Drug Consumption (History Data) by Regions
  • 7.2. North America
    • 7.2.1. North America Asthma and COPD Drug Consumption by Type
    • 7.2.2. North America Asthma and COPD Drug Consumption by Application
    • 7.2.3. North America Asthma and COPD Drug Consumption by Countries
    • 7.2.4. United States
    • 7.2.5. Canada
    • 7.2.6. Mexico
  • 7.3. Europe
    • 7.3.1. Europe Asthma and COPD Drug Consumption by Type
    • 7.3.2. Europe Asthma and COPD Drug Consumption by Application
    • 7.3.3. Europe Asthma and COPD Drug Consumption by Countries
    • 7.3.4. Germany
    • 7.3.5. France
    • 7.3.6. UK
    • 7.3.7. Italy
    • 7.3.8. Russia
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Asthma and COPD Drug Consumption by Type
    • 7.4.2. Asia Pacific Asthma and COPD Drug Consumption by Application
    • 7.4.3. Asia Pacific Asthma and COPD Drug Consumption by Countries
    • 7.4.4. China
    • 7.4.5. Japan
    • 7.4.6. Korea
    • 7.4.7. India
    • 7.4.8. Australia
    • 7.4.9. Indonesia
    • 7.4.10 Thailand
    • 7.4.11 Malaysia
    • 7.4.12 Philippines
    • 7.4.13 Vietnam
  • 7.5. Central & South America
    • 7.5.1. Central & South America Asthma and COPD Drug Consumption by Type
    • 7.5.2. Central & South America Asthma and COPD Drug Consumption by Application
    • 7.5.3. Central & South America Asthma and COPD Drug Consumption by Countries
    • 7.5.4. Brazil
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Asthma and COPD Drug Consumption by Type
    • 7.6.2. Middle East and Africa Asthma and COPD Drug Consumption by Application

8. Company Profiles

  • 8.1. Boehringer Ingelheim
    • 8.1.1. Boehringer Ingelheim Company Details
    • 8.1.2. Company Description and Business Overview
    • 8.1.3. Production and Revenue of Asthma and COPD Drug
    • 8.1.4. Asthma and COPD Drug Product Introduction
    • 8.1.5. Boehringer Ingelheim Recent Development
  • 8.2. GlaxoSmithKline
    • 8.2.1. GlaxoSmithKline Company Details
    • 8.2.2. Company Description and Business Overview
    • 8.2.3. Production and Revenue of Asthma and COPD Drug
    • 8.2.4. Asthma and COPD Drug Product Introduction
    • 8.2.5. GlaxoSmithKline Recent Development
  • 8.3. Merck and Co
    • 8.3.1. Merck and Co Company Details
    • 8.3.2. Company Description and Business Overview
    • 8.3.3. Production and Revenue of Asthma and COPD Drug
    • 8.3.4. Asthma and COPD Drug Product Introduction
    • 8.3.5. Merck and Co Recent Development
  • 8.4. Novartis AG
    • 8.4.1. Novartis AG Company Details
    • 8.4.2. Company Description and Business Overview
    • 8.4.3. Production and Revenue of Asthma and COPD Drug
    • 8.4.4. Asthma and COPD Drug Product Introduction
    • 8.4.5. Novartis AG Recent Development
  • 8.5. AstraZeneca
    • 8.5.1. AstraZeneca Company Details
    • 8.5.2. Company Description and Business Overview
    • 8.5.3. Production and Revenue of Asthma and COPD Drug
    • 8.5.4. Asthma and COPD Drug Product Introduction
    • 8.5.5. AstraZeneca Recent Development
  • 8.6. F. Hoffmann-La Roche
    • 8.6.1. F. Hoffmann-La Roche Company Details
    • 8.6.2. Company Description and Business Overview
    • 8.6.3. Production and Revenue of Asthma and COPD Drug
    • 8.6.4. Asthma and COPD Drug Product Introduction
    • 8.6.5. F. Hoffmann-La Roche Recent Development

9. Market Forecast: Production Side

  • 9.1. Production and Production Value Forecast
    • 9.1.1. Global Asthma and COPD Drug Capacity, Production Forecast 2018-2025
    • 9.1.2. Global Asthma and COPD Drug Production Value Forecast 2018-2025
  • 9.2. Asthma and COPD Drug Production and Production Value Forecast by Regions
    • 9.2.1. Global Asthma and COPD Drug Production Value Forecast by Regions
    • 9.2.2. Global Asthma and COPD Drug Production Forecast by Regions
  • 9.3. Asthma and COPD Drug Key Producers Forecast
    • 9.3.1. United States
    • 9.3.2. Europe
    • 9.3.3. China
    • 9.3.4. Japan
    • 9.3.5. Other Regions
  • 9.4. Forecast by Type
    • 9.4.1. Global Asthma and COPD Drug Production Forecast by Type
    • 9.4.2. Global Asthma and COPD Drug Production Value Forecast by Type

10 Market Forecast: Consumption Side

  • 10.1. Consumption Forecast by Application
  • 10.2. Asthma and COPD Drug Consumption Forecast by Regions
  • 10.3. North America Market Consumption Forecast
    • 10.3.1. North America Asthma and COPD Drug Consumption Forecast by Countries 2018-2025
    • 10.3.2. United States
    • 10.3.3. Canada
    • 10.3.4. Mexico
  • 10.4. Europe Market Consumption Forecast
    • 10.4.1. Europe Asthma and COPD Drug Consumption Forecast by Countries 2018-2025
    • 10.4.2. Germany
    • 10.4.3. France
    • 10.4.4. UK
    • 10.4.5. Italy
    • 10.4.6. Russia
  • 10.5. Asia Pacific Market Consumption Forecast
    • 10.5.1. Asia Pacific Asthma and COPD Drug Consumption Forecast by Countries 2018-2025
    • 10.5.2. China
    • 10.5.3. Japan
    • 10.5.4. Korea
    • 10.5.5. India
    • 10.5.6. Australia
    • 10.5.7. Indonesia
    • 10.5.8. Thailand
    • 10.5.9. Malaysia
    • 10.5.10 Philippines
    • 10.5.11 Vietnam
  • 10.6. Central & South America Market Consumption Forecast
    • 10.6.1. Central & South America Asthma and COPD Drug Consumption Forecast by Country 2018-2025
    • 10.6.2. Brazil
  • 10.7. Middle East and Africa Market Consumption Forecast
    • 10.7.1. Middle East and Africa Asthma and COPD Drug Consumption Forecast by Countries 2018-2025
    • 10.7.2. Middle East and Africa
    • 10.7.3. GCC Countries
    • 10.7.4. Egypt
    • 10.7.5. South Africa

11 Value Chain and Sales Channels Analysis

  • 11.1. Value Chain Analysis
  • 11.2. Sales Channels Analysis
    • 11.2.1. Asthma and COPD Drug Sales Channels
    • 11.2.2. Asthma and COPD Drug Distributors
  • 11.3. Asthma and COPD Drug Customers

12 Opportunities & Challenges, Threat and Affecting Factors

  • 12.1. Market Opportunities
  • 12.2. Market Challenges
  • 12.3. Porter's Five Forces Analysis
  • 12.4. Macroscopic Indicator
    • 12.4.1. GDP for Major Regions
    • 12.4.2. Price of Raw Materials in Dollars: Evolution

13 Key Findings

14 Appendix

  • 14.1. Research Methodology
    • 14.1.1. Methodology/Research Approach
      • 14.1.1.1. Research Programs/Design
      • 14.1.1.2. Market Size Estimation
      • 14.1.1.3. Market Breakdown and Data Triangulation
    • 14.1.2. Data Source
      • 14.1.2.1. Secondary Sources
      • 14.1.2.2. Primary Sources
  • 14.2. Author Details
  • 14.3. Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.